Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease

6. Juni 2026 aktualisiert von: Fatih Söke, Saglik Bilimleri Universitesi

Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease

The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:

- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.

Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.

Participants will:

  • Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
  • Participate in assessments at the study clinic before and after exercise training.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

39

Phase

  • Unzutreffend

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
  • Being in stages 1-3 according to the Hoehn-Yahr Scale.

Exclusion Criteria:

  • Presence of a neurological disease other than Parkinson's disease
  • Cognitive impairment (Standardized Mini Mental Test score less than 24)
  • Having undergone deep brain stimulation surgery
  • Having a visual, auditory, or perceptual problem
  • Having any orthopedic, rheumatological, or other condition that may affect walking and balance.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Single Task Training
Single task balance and walking training
Sonstiges: Single Task Exercise Training
Single task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period.
Experimental: Motor-Motor Dual Task Training
Motor-motor dual task balance and walking training
Sonstiges: Motor-Motor Dual Task Exercise Training
Motor-motor dual task balance and walking exercises. Motor-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
Experimental: Cognitive-Motor Dual Task Training
Cognitive-motor dual task balance and walking training
Sonstiges: Cognitive-Motor Dual Task Exercise Training
Cognitive-motor dual task balance and walking exercises. Cognitive-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3
Zeitfenster: From enrollment to the end of training at 6 weeks
UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease. The motor symptoms section, which is the third section of this scale, will be used.
From enrollment to the end of training at 6 weeks
Hoehn & Yahr Scale
Zeitfenster: From enrollment to the end of treatment at 6 weeks
It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.
From enrollment to the end of treatment at 6 weeks
Single-Leg Stance Test
Zeitfenster: From enrollment to the end of treatment at 6 weeks
This is a test method used to assess static balance. The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open. The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds. The time the participant maintains their balance is recorded.
From enrollment to the end of treatment at 6 weeks
Functional Reach Test
Zeitfenster: From enrollment to the end of treatment at 6 weeks
This test is designed to assess dynamic balance. In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended. The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall. The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position. The difference between the two marks is measured with a tape measure.
From enrollment to the end of treatment at 6 weeks
10 Meter Walking Test
Zeitfenster: From enrollment to the end of treatment at 6 weeks
Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.
From enrollment to the end of treatment at 6 weeks
Motor-Motor Dual Task Cost of Walking
Zeitfenster: From enrollment to the end of treatment at 6 weeks

To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula:

[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
From enrollment to the end of treatment at 6 weeks
Cognitive-Motor Dual Task Cost of Walking
Zeitfenster: From enrollment to the end of treatment at 6 weeks

To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula:

[(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]
From enrollment to the end of treatment at 6 weeks
Timed Up and Go Test
Zeitfenster: From enrollment to the end of treatment at 6 weeks
This test is used to assess functional mobility levels. The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it. The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down. The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.
From enrollment to the end of treatment at 6 weeks
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2
Zeitfenster: From enrollment to the end of treatment at 6 weeks
It consists of thirteen items. The assessment is based on anamnesis information regarding how the patient functions in various activities. The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities. Each item is evaluated using a scoring system between '0' and '4'.
From enrollment to the end of treatment at 6 weeks
Dual Task Questionnaire
Zeitfenster: From enrollment to the end of treatment at 6 weeks
This test is used to assess the challenges encountered in daily tasks involving dual work. It consists of 10 questions and is administered via face-to-face interview. Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.
From enrollment to the end of treatment at 6 weeks
Trail Making Test
Zeitfenster: From enrollment to the end of treatment at 6 weeks
It is used to assess executive functions and attention. The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded. In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.
From enrollment to the end of treatment at 6 weeks
Activity-Specific Balance Confidence Scale
Zeitfenster: From enrollment to the end of treatment at 6 weeks
This is a commonly used scale for assessing balance confidence. The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady. It consists of sixteen items. Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident). The base score is calculated by dividing the total score by 16. Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.
From enrollment to the end of treatment at 6 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Saglik Bilimleri Universitesi

Mitarbeiter

Eskisehir Osmangazi University
Anadolu University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

15. Juni 2026

Primärer Abschluss (Geschätzt)

1. September 2026

Studienabschluss (Geschätzt)

15. September 2026

Studienanmeldedaten

Zuerst eingereicht

6. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

6. Juni 2026

Zuerst gepostet (Tatsächlich)

11. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

11. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

6. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • 2026-152

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Parkinson-Krankheit (PD)

Klinische Studien zur Single Task Exercise Training

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Malta

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

Abonnieren